Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)

Introduction In France and Europe,1–4 medicine and healthcare products regulatory agencies have been proactively engaging in health democracy for the last decade. Since 2002, the French legislation has evolved to guarantee the rights of healthcare system’s users.5 Thus, eligible patients and health...

Full description

Saved in:

Bibliographic Details
Published in:	BMJ global health Vol. 8; no. 5; p. e011966
Main Authors:	Belgodère, Laëtitia, Pougheon Bertrand, Dominique, Jaulent, Marie Christine, Rabeharisoa, Vololona, Janssens, Walter, Rollason, Victoria, Barbot, Janine, Vernant, Jean Paul, Oualikene Gonin, Wahiba, Maison, Patrick, Ankri, Joel, Barouki, Robert, Bastos, Henri, Bellissant, Éric, Druml, Christiane, Ezan, Éric, Houssin, Didier, Monteiro, Maria Emilia, Bertrand, Dominique Pougheon, Sautou, Valérie, Ankri, Joël, Jaulent, Marie-Christine, Vernant, Jean-Paul
Format:	Journal Article
Language:	English
Published:	England BMJ Publishing Group Ltd 01.05.2023 BMJ Publishing Group LTD BMJ Publishing Group
Subjects:	Advisors Breast milk Caregivers Commentary Decision making Democracy Health care Health care policy health policy health systems evaluation Humanities and Social Sciences Humans Legislation Medical personnel Participation Patient safety Pharmacovigilance Professional ethics Public Health Public involvement Regulation Regulatory agencies Risk Assessment treatment Whistleblowing health systems evaluation treatment health policy public health
ISSN:	2059-7908, 2059-7908
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!